Gender Bias in Covid-19 Infection
DOI:
https://doi.org/10.31033/ijrasb.9.3.3Keywords:
Covid-19, CRP, Gender, SARS-CoV-2Abstract
Coronavirus disease 2019 (COVID-19), a lethal respiratory infection caused by the coronavirus 2 (SARS-CoV-2) that causes severe acute respiratory syndrome, has spread over the world. The aim was to compare between male and female patients with COVID-19 or SARS. Serum samples were obtained from 58 patients with COVID-19 infection 27 female and 31 male with age median 53.2Years and a total mean concentration of CRP 113.6 mg / L where in females the mean was 90 mg/L while in males was 109 mg/L, the highest mean were 288 mg/L in age between 70_80 years. Conclusion; CRP showed different distribution feature and existed differences in various ages and according to genus.
Downloads
References
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China: a descriptive study. Lancet 2020;395(10223):507–13,http://dx.doi.org/ 10.1016/ S0140-6736(20)30211-7.
Lin C, Ding Y, Xie B, Sun Z, Li X, Chen Z, et al. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease. Clin Imaging 2020;63(3):7–9, http://dx.doi.org/10.1016/j.clinimag.2020.02.008.
Warusevitane A, Karunatilake D, Sim J, Smith C, Roffe C. Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein. PloS one 2016;11(3):e0150269, http://dx.doi.org/10.1371/journal.pone.0150269
Bilgir O, Bilgir F, Calan M. Comparison of pre-and post-levothyroxine highsensitivity C-reactive protein and fetuin-Alevels in subclinical hypothyroidism. Clinics 2015;70(2):97–101, http://dx.doi.org/10.6061/clinics/2015(02)05.
Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers. World J Crit Care Med 2019;8(5):59–71, http://dx.doi.org/10.5492/wjccm.v8.i5.59.
Matsumoto H, Kasai T, Sato A, Ishiwata S, Yatsu S, Shitara J, et al. Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels 2019;34(12):1961–8, http://dx.doi.org/10.1007/s00380-019-01435-9.
Ahnach M and et al. C-REACTIVE PROTEIN AS AN EARLY PREDICTOR OF COVID-19 SEVERITY. J Med Biochem 39: 1–8, 2020 DOI: 10.5937/jomb0-27554
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, 2020; S2213-2600(20)30079-5.
Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy, 2020; doi:10.1111/all.14238.
Luo X and et al. Prognostic value of C-reactive protein in patients with COVID-19. Clinical Infectious Diseases doi: 10.1093/cid/ciaa641
Smilowitz N R and et al. C-reactive protein and clinical outcomes in patients with COVID-19. European Heart Journal (2021) 00, 1–10 doi:10.1093/eurheartj/ehaa1103
Vasileva D, Badawi A. C-reactive protein as a biomarker of severe H1N1 influenza. Inflamm Res 2019;68:39–46.
Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020;92:791–796.
Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J; China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med 2020;180:1081–1089
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–943.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR Jr, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM and Safford MM. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382: 2372–2374
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. (2020) 382:1199–207. doi: 10.1056/NEJMoa2001316
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. (2020). doi: 10.1111/all.14238. [Epub ahead of print].
Jin J M and et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020; 8: 152. doi: 10.3389/fpubh.2020.00152
Patel SK, Velkoska E, Burrell LM. Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? Clin Exp Pharmacol Physiol. (2013) 40:551–9. doi: 10.1111/1440-1681.12069
Bwire G M. Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?. SN Compr Clin Med. 2020 Jun 4 : 1–3. doi: 10.1007/s42399-020-00341-w
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal for Research in Applied Sciences and Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
editor@ijrasb.com 